11:22 PM EDT, 10/18/2026 (MT Newswires) -- Alcon (ALC.SW) received approval from the US Food and Drug Administration for its Brytly eye drops to relieve redness for up to 12 hours. The Swiss eye care company said on Oct. 16 that the eye whitener is clinically proven to be safe and effective, with a low risk of redness rebound and tachyphylaxis, or when the treatment gradually loses its effect with repeated use. The eye drop is expected to be available in the US in the coming months.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.